Related Experiment Video
Updated: Mar 8, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Endogenous bone morphogenetic protein 2 plays a role in vascular smooth muscle cell calcification induced by
Mingshu Sun1, Qing Chang2, Miaomiao Xin1
11 Department of Rheumatology and Clinical Immunology, the Affiliated Hospital of Qingdao University, Qingdao, China.
Insights
Interleukin-6 (IL-6) promotes vascular calcification in rheumatoid arthritis by inducing osteogenic differentiation in smooth muscle cells via bone morphogenetic protein-2 (BMP2). This highlights a key mechanism in RA cardiovascular disease.
Area of Science:
- Cardiovascular Biology
- Rheumatology
- Cellular and Molecular Medicine
Background:
- Systemic inflammation, particularly elevated serum interleukin-6 (IL-6), is linked to vascular calcification and cardiovascular disease, the primary cause of mortality in rheumatoid arthritis (RA).
- The precise mechanisms by which IL-6 contributes to vascular calcification in RA remain incompletely understood.
Purpose of the Study:
- To investigate the role of IL-6 in vascular calcification using a human umbilical artery smooth muscle cell (HUASMC) culture model.
- To elucidate the molecular pathways, specifically the involvement of bone morphogenetic protein-2 (BMP2), through which IL-6 induces calcification.
Main Methods:
- Cultured HUASMCs were treated with recombinant human IL-6 (rhIL-6) to assess calcification.
- Measured calcium deposition, calcium concentration, and mRNA/protein levels of BMP2, bone-specific alkaline phosphatase (BAP), osteoprotegerin (OPG), and osteopontin (OPN).
- Utilized anti-BMP2 small interfering RNA (siRNA) to investigate BMP2's role in rhIL-6-induced calcification.
Main Results:
- rhIL-6 significantly induced calcification and osteogenic differentiation in HUASMCs in a time- and dose-dependent manner.
- rhIL-6 upregulated the expression of BMP2, BAP, OPG, and OPN.
- Knockdown of BMP2 using siRNA partially inhibited rhIL-6-induced calcification and reduced the expression of associated osteogenic markers.
Conclusions:
- Recombinant human IL-6 induces extracellular calcification and osteogenic differentiation of human artery smooth muscle cells in vitro.
- This effect is mediated, at least in part, through the upregulation of endogenous BMP2.
- The IL-6/BMP2 pathway represents a potential mechanism underlying vascular calcification in rheumatoid arthritis.
Abstract:
Systemic inflammation is involved in vascular calcification and cardiovascular disease which is the leading cause of mortality in rheumatoid arthritis (RA). A high level of serum interleukin (IL)-6 plays a key role in local and systemic inflammation in RA. However, the underlying mechanisms remain unclear. We established a human umbilical artery smooth muscle cell (HUASMC) culturing method to investigate the possible role of IL-6 on vascular calcification. HUASMCs were obtained from umbilical arteries of healthy neonates. To detect calcification effects, HUASMCs were treated with (experimental group) or without (control group) recombinant human (rh) IL-6. The calcium deposition stain and calcium concentrations were measured, as well as the mRNA and protein levels of the regulating factor of osteogenic differentiation-bone morphogenetic protein (BMP) 2 and those calcifying related molecules including bone-specific alkaline phosphatase (BAP), osteoprotegerin (OPG), and osteopontin (OPN). Our study showed that rhIL-6 induced calcification of HUASMCs in a time- and dose-dependent manner, and upregulated expressions of BMP2, BAP, OPG, and OPN of HUASMCs. We then used the anti-BMP2 siRNA to knockdown the expression of endogenous BMP2 to confirm its role. HUASMCs were transfected with negative siRNA (control group) or the valid anti-BMP2 siRNA (experimental group) before they were treated with rhIL-6. Cells transfected with negative siRNA without IL-6 stimulating served as the blank group. The results showed that anti-BMP2 siRNA markedly decreased expressions of BMP2, BAP, OPG, and OPN, and also partly reduced the calcification of HUASMCs induced by rhIL-6. Collectively, according to our study, rhIL-6 could induce the extracellular calcification and osteogenic differentiation of human artery smooth muscle cells through upregulating endogenous BMP2 in vitro. This may be one of the underlying mechanisms of the overwhelming vascular calcification in RA.
More Related Videos
10:32Author Spotlight: Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(Ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate
Published on: May 19, 2023
06:47Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
Bone Formation by Endochondral Ossification
Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...